Back to results
CompletedPhase 2

Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer

NCT04033419

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

View on ClinicalTrials.gov
Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer — TrialFind